MannKind Corporation (MNKD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Core Insights - MannKind Corporation has transitioned from a single revenue stream to a diversified commercial organization with multiple FDA-approved products, indicating significant growth and transformation in its business model [2]. Group 1: Company Overview - The presentation features Michael Castagna, CEO of MannKind Corporation, and Chris Prentiss, CFO, highlighting the company's recent developments and strategic direction [1]. - The year 2025 marked a pivotal moment for MannKind, closing out with strong momentum and a more robust product portfolio [2].